Recipient cytomegalovirus (CMV) seropositivity is known to be a risk factor for CMV
reactivation after allogeneic hematopoietic stem cell transplantation (allo-HCT). We explored …

Cytomegalovirus (CMV) represents one of the most common infectious complications after
allogeneic hematopoietic stem cell transplantation (allo-HSCT). Currently, a common …

Background This retrospective study was aimed at establishing a clinical score to stratify the
risk of cytomegalovirus (CMV) reactivation in patients undergoing allogeneic hematopoietic …

Cytomegalovirus (CMV) reactivation remains one of the main infectious complications
following hematopoietic stem cell transplantation (HSCT). In this study, we explored the role …

Background We aimed to investigate factors associated with cytomegalovirus (CMV) viremia
and CMV disease and its impact on post-transplant outcomes including overall survival (OS) …

Previous studies have reported a beneficial effect from cytomegalovirus (CMV) reactivation
after allogeneic hematopoietic stem cell transplantation (alloHCT) on immune reconstitution …

OBJECTIVE: Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in
allogeneic hematopoietic stem cell transplantation (AHSCT) recipients. Current practice …

Background Cytomegalovirus (CMV) reactivation is a frequent complication after allogeneic
hematopoietic cell transplant (alloHCT). Method We analyzed 159 alloHCT recipients with …

Pre-emptive therapy is an effective approach for cytomegalovirus (CMV) control; however,
refractory CMV still occurs in a considerable group of recipients after allogeneic …

Cytomegalovirus (CMV) disease is a major cause of infectious complications in allogeneic
hematopoietic stem cell transplantation (allo-HSCT). Although patients undergoing allo …